PTA-PVR: Marinomed Biotech AG: Correction of a Release according to art. 135 section 2 BörseG from 25.01.2021

Tuesday, 26. January 2021 12:19

Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)

Korneuburg (pta023/26.01.2021/12:19) - Release of Announcement according to art. 135 section 2 BörseG

Notification of Major Holdings

1. Issuer:
Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Name: Acropora Beteiligungs GmbH
City and country of registered office: Vienna, Austria

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3
Mohammed Al Sheikh
Abdulmohsen Al Sheikh

5. Date on which threshold was crossed or reached
21.01.2021

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached 13.86 0.00 13.86 1,474,731
Position of previous notification 16.59 0.00 16.59

7. Notified details of the resulting situation

7.a. Voting rights attached to shares

ISIN code absolute direct (Sec 130 BörseG 2018) absolute indirect (Sec 133 BörseG 2018) in % direct (Sec 130 BörseG 2018) in % indirect (Sec 133 BörseG 2018)
ATMARINOMED6 0 204,410 0.00 13.86
Total: 204,410 13.86

7.b.1. Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

Type of instrument Expiration Date Exercise Period Voting Rights Absolute Voting Rights in %
Total:

7.b.2 Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018

Type of instrument Expiration Date Exercise Period Physical /Cash Settlement Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity.

No. Name Directly controlled by No. Shares held directly (%) Financial/other instruments held directly (%) Total of both (%)
1 Abdulmohsen Al Sheikh
2 Mohammed Al Sheikh
3 Acropora Beteiligungs GmbH 1,2 13.86 13.86

9. In case of proxy voting

Date of general meeting: N/A

10. Additional Information
The participation notification is based on the fact that the threshold is not reached after the sale of 38,450 shares.

(end)

emitter: Marinomed Biotech AG
address: Hovengasse 25, 2100 Korneuburg
country: Austria
contact person: Elisabeth Schön
phone: +43226290300
e-mail: elisabeth.schoen@marinomed.com
website: www.marinomed.com

ISIN(s): ATMARINOMED6 (share)
stock exchanges: official trade in Vienna

[ source: http://www.pressetext.com/news/20210126023 ]

Related Links: Marinomed Biotech AG
Author: